CCNB1IP1 and cancer: Our results further demonstrated the ability of CCNB1IP1 to ubiquitinate cyclin B1, thus targeting the E3 ubiquitin ligase involved in cell cycle regulation is expected to provide new therapeutic strategies for cancer therapy.